Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Journal for Equity in Health
Published in: International Journal for Equity in Health 1/2017

Open Access 01-12-2017 | Research

Trends in healthcare expenditure among people living with HIV/AIDS in the United States: evidence from 10 Years of nationally representative data

Authors: Tiarney D. Ritchwood, Kinfe G. Bishu, Leonard E. Egede

Published in: International Journal for Equity in Health | Issue 1/2017

Login to get access

Abstract

Background

While previous studies have examined HIV cost expenditures within the United States, the majority of these studies focused on data collected prior to or shortly after the advent and uptake of antiretroviral therapy, focused only on a short time frame, or did not provide cost comparisons between HIV/AIDS and other chronic conditions. It is critical that researchers provide accurate and updated information regarding the costs of HIV care to assist key stakeholders with economic planning, policy development, and resource allocation.

Methods

We used data from the Medical Expenditure Panel Survey-Household Component for the years 2002–2011, which represents a nationally representative U.S. civilian non-institutionalized population. Using generalized linear modeling, we estimated the adjusted direct medical expenditures by HIV/AIDS status after controlling for confounding factors.

Results

Data were from 342,732 people living with HIV/AIDS. After adjusting for socio-demographic factors, comorbidities and time trend covariates, the total direct expenditures for HIV/AIDS was $31,147 (95% CI $23,645–$38,648) or 800–900% higher when compared to those without HIV/AIDS (i.e., diabetes, stroke, and cardiovascular disease). Based on the adjusted mean, the aggregate cost of HIV/AIDS was approximately $10.7 billion higher than the costs for those without HIV/AIDS.

Conclusions

Our estimates of cost expenditures associated with HIV care over a 10-year period show a financial burden that exceeds previous estimates of direct medical costs. There is a strong need for investment in combination prevention and intervention programs, as they have the potential to reduce HIV transmission, and facilitate longer and healthier living thereby reducing the economic burden of HIV/AIDS.
Literature
1.
2.
Fleishman JA, et al. Hospital and outpatient health services utilization among HIV-infected adults in care 2000–2002. Med care. 2005;43(9):III40–52.PubMed
3.
Berry SA, et al. Trends in reasons for hospitalization in a multisite United States cohort of persons living with HIV, 2001-2008. Journal of acquired immune deficiency syndromes (1999). 2012;59(4):368.CrossRef
4.
Bozzette SA, et al. Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy. N Engl J Med. 2001;344(11):817–23.CrossRefPubMed
5.
Schackman BR, et al. The lifetime medical cost savings from preventing HIV in the United States. Med Care. 2015;53(4):293.PubMedPubMedCentral
6.
Hutchinson AB, et al. The economic burden of HIV in the United States in the era of highly active antiretroviral therapy: evidence of continuing racial and ethnic differences. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2006;43(4):451–7.CrossRefPubMed
7.
Chen RY, et al. Distribution of health care expenditures for HIV-infected patients. Clin Infect Dis. 2006;42(7):1003–10.CrossRefPubMed
8.
Farnham PG, et al. Updates of lifetime costs of care and quality-of-life estimates for HIV-infected persons in the United States: late versus early diagnosis and entry into care. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2013;64(2):183–9.CrossRefPubMed
9.
Gebo KA, et al. Costs of HIV medical care in the era of highly active antiretroviral therapy. AIDS. 1999;13(8):963–9.CrossRefPubMed
10.
Gebo KA, Diener-West M, Moore RD. Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2001;27(2):143–52.CrossRefPubMed
11.
12.
13.
Mihaylova B, et al. Review of statistical methods for analysing healthcare resources and costs. Health Econ. 2011;20(8):897–916.CrossRefPubMed
14.
Duan N, et al. A comparison of alternative models for the demand for medical care. J Bus Econ Stat. 1983;1(2):115–26.
15.
Belotti F, Deb P, Manning WG, Norton EC. Tpm: estimating two-part models. Stata J. 2012;5(2):1–13.
16.
Zhuo X, et al. The lifetime cost of diabetes and its implications for diabetes prevention. Diabetes Care. 2014;37(9):2557–64.CrossRefPubMed
17.
Hardin JW, Hilbe JM, Hilbe J. Generalized linear models and extensions: College Station, TX: Stata press; 2007.
18.
Shapiro MF, et al. Variations in the care of HIV-infected adults in the United States: results from the HIV cost and services utilization study. JAMA. 1999;281(24):2305–15.CrossRefPubMed
19.
20.
Walensky RP, et al. Economic savings versus health losses: the cost-effectiveness of generic antiretroviral therapy in the United States. Ann Intern Med. 2013;158(2):84–92.CrossRefPubMedPubMedCentral
21.
22.
Metadata
Title
Trends in healthcare expenditure among people living with HIV/AIDS in the United States: evidence from 10 Years of nationally representative data
Authors
Tiarney D. Ritchwood
Kinfe G. Bishu
Leonard E. Egede
Publication date
01-12-2017
Publisher
BioMed Central
Published in
International Journal for Equity in Health / Issue 1/2017
Electronic ISSN: 1475-9276
DOI
https://doi.org/10.1186/s12939-017-0683-y

Other articles of this Issue 1/2017

International Journal for Equity in Health 1/2017 Go to the issue

Review

The scope and impact of mobile health clinics in the United States: a literature review

Research

Multidimensional poverty and catastrophic health spending in the mountainous regions of Myanmar, Nepal and India

Research

Control under times of uncertainty: the relationship between hospital competition and physician-patient disputes

Research

Obesity in Scotland: a persistent inequality

Research

Implementing guidelines and training initiatives to improve cross-cultural communication in primary care consultations: a qualitative participatory European study

Research

Slender women and overweight men: gender differences in the educational gradient in body weight in South Korea